Compare Pinterest Inc (PINS) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Pinterest (PINS) trades at $21.40, up 5.37% with bullish technical signals despite mixed oscillators. The company shows strong revenue growth from $2.8B in 2022 to $4.2B in 2025, with recent earnings beats and a 79.5% gross margin. Analyst consensus is bullish with a $27.93 price target, though high P/E of 60.4 and insider selling pose valuation concerns.

Outlook remains positive driven by international monetization and new ad products, but risks include competitive pressure and reliance on advertising revenue. The stock offers growth potential if execution continues, though current valuation demands careful monitoring of earnings sustainability.

Regeneron Pharmaceuticals (REGN) trades at $746.54, up 0.6% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent news highlights a significant $8 billion immunology alliance expansion with Sanofi, providing substantial upfront and milestone payments. Cash flow improved in 2025, and profitability remains robust with a net income margin of 27.86%.

The outlook is positive, driven by the expanded Sanofi partnership and promising clinical trial updates, though technical indicators suggest near-term resistance. Risks include competitive pressures in key drug markets and reliance on successful drug development. Analysts are bullish with a consensus price target of $849.84, indicating potential upside from current levels.